Zai Lab (ZLAB) Accounts Payables (2016 - 2026)
Zai Lab (ZLAB) reported Accounts Payables of $126.2 million for Q1 2026, up 22.47% on a YoY basis from $103.0 million in Q1 2025, and down 10.9% sequentially from $141.6 million in Q4 2025.
Zai Lab (ZLAB) Accounts Payables (2016 - 2026) Analysis & Trends
Zai Lab (ZLAB) has 11 years of Accounts Payables data on file, last reported at $126.2 million in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables rose 22.47% year-over-year to $126.2 million; the trailing twelve-month figure through Mar 2026 stood at $126.2 million (up 22.47% YoY), and the FY2025 full-year result was $141.6 million, up 40.34% from the prior year.
- Accounts Payables fell to $126.2 million in Q1 2026, from $141.6 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $141.6 million in Q4 2025 to a low of $55.0 million in Q3 2023.
- A 5-year average of $98.8 million and a median of $100.9 million in 2024 frame the typical range for Accounts Payables.
- Peak annual rise in Accounts Payables reached 137.02% in 2022, while the deepest fall reached 47.71% in 2022.
- Tracing ZLAB's Accounts Payables over 5 years: stood at $66.0 million in 2022, then soared by 71.27% to $113.0 million in 2023, then fell by 10.7% to $100.9 million in 2024, then soared by 40.34% to $141.6 million in 2025, then dropped by 10.9% to $126.2 million in 2026.
- Business Quant data shows ZLAB's Accounts Payables at $126.2 million in Q1 2026, $141.6 million in Q4 2025, and $99.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 10.62 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 8.64 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 423.55 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 80.54 Mn |
| 10 | Zai Lab | 21.37 Bn | 21.37 Bn | -34.26 Mn | 126.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 126.17 Mn |
| Dec 31, 2025 | 141.61 Mn |
| Sep 30, 2025 | 99.71 Mn |
| Jun 30, 2025 | 107.36 Mn |
| Mar 31, 2025 | 103.02 Mn |
| Dec 31, 2024 | 100.91 Mn |
| Sep 30, 2024 | 120.65 Mn |
| Jun 30, 2024 | 127.34 Mn |
| Mar 31, 2024 | 88.12 Mn |
| Dec 31, 2023 | 112.99 Mn |
| Sep 30, 2023 | 55.02 Mn |
| Jun 30, 2023 | 67.03 Mn |
| Mar 31, 2023 | 66.36 Mn |
| Dec 31, 2022 | 65.97 Mn |
| Sep 30, 2022 | 90.11 Mn |
| Jun 30, 2022 | 108.44 Mn |
| Mar 31, 2022 | 98.16 Mn |
| Dec 31, 2021 | 126.16 Mn |
| Sep 30, 2021 | 51.41 Mn |
| Jun 30, 2021 | 125.62 Mn |